Error: Could not add to watchlist. X
+ Watchlist

Aberdeen Swiss Funds Global Pharma Equity Fund

SVBPHNI:SW
1,902.27
USD
3.23
0.17%
As of 1/18/2018
Fund Type
Open-End Fund
52Wk Range
1,484.71 - 1,906.32
1 Yr Return
27.51%
YTD Return
2.98%
Before it's here, it's on the Bloomberg Terminal.
Learn More
Previous Close
1,905.50
52Wk Range
1,484.71 - 1,906.32
1 Yr Return
26.59%
YTD Return
2.98%
Fund Type
Open-End Fund
Objective
Foreign Blend
Asset Class Focus
Equity
Geographic Focus
Global
NAV (on 01/18/2018)
1,902.27
Total Assets (m USD) (on 01/18/2018)
88.976
Inception Date
09/30/1959
Last Dividend (on 11/21/2017)
6.7
Dividend Indicated Gross Yield
0.35%
Fund Managers
-
Front Load Fee
5.00%
Back Load Fee
2.00%
Redemption Fee
2.00%
12b-1 Fee
-
Current Mgmt Fee
1.60%
Expense Ratio
1.67%

Top Fund Holdings

Name Position Value % of Fund
28.70 k 7.33 m 8.50
75.90 k 6.50 m 7.54
112.90 k 5.40 m 6.26
41.00 k 5.33 m 6.18
65.80 k 4.20 m 4.86
48.30 k 3.93 m 4.55
34.10 k 3.34 m 3.87
24.00 k 3.27 m 3.79
14.90 k 3.17 m 3.67
648.00 k 3.16 m 3.66
Profile
Aberdeen Swiss Equity Fund Global Pharma is an open-end fund incorporated in Switzerland. The Fund invests worldwide in companies that are active in the pharmaceuticals, biotechnology and medical technology sectors. The Fund focuses on the United States and offers investors a transparent way to invest in the complex pharmaceuticals and biotechnology sectors.
Address
Credit Suisse Asset Management Funds
Sihlcity - Kalandergasse 4
CH-8070 Zurich
Switzerland
Phone
41-44-335-11-11 Tel